Skip to main content
Pharmena S.A. logo

Pharmena S.A. — Investor Relations & Filings

Ticker · PHR ISIN · PLPHRMN00011 LEI · 259400RHT936BBKW0955 WAR Manufacturing
Open in API
Filings indexed 649 across all filing types
Latest filing 2022-03-31 Regulatory Filings
Country PL Poland
Listing WAR PHR

About Pharmena S.A.

https://www.pharmena.eu/

Pharmena S.A. is a specialty healthcare company focused on the development and commercialization of innovative products based on its patented active ingredient, 1-MNA. This molecule is a naturally occurring metabolite of niacin (vitamin B3) that plays a crucial role in cellular metabolism. The company's technology leverages the ability of 1-MNA to optimize the levels of the coenzyme NAD+, which decline with age and are vital for cellular function and regeneration. The product portfolio includes specialized cosmeceuticals, such as the Dermena line for hair loss, and dietary supplements designed to address the effects of cellular aging.

Recent filings

Filing Released Lang Actions
Oświadczenie zarządu skonsolidowane sprawozdanie za 2021 - podpis
Regulatory Filings Classification · 85% confidence The provided document text consists entirely of XML Digital Signature blocks (specifically XAdES format, indicated by namespaces like 'ds' and 'xades'). These blocks contain cryptographic information, references to a file named 'Pharmena_oswiadczenie_zarzadu-skons_2021.xhtml', and signing timestamps (e.g., 2022-03-31). This structure strongly suggests the document is a digitally signed statement or declaration, likely related to financial reporting or management assertions, rather than the report itself or a general announcement. Keywords like 'oswiadczenie zarzadu' (management statement/declaration) and the presence of multiple signatures point towards a formal declaration accompanying a financial filing. Given the options, this is not a standard 10-K, ER, or IR. It is most closely related to formal governance or management reporting. If 'oswiadczenie zarzadu' refers to a Management Discussion and Analysis (MDA) or a similar formal statement accompanying financial results, MDA is the best fit. However, since the content is purely the signature block, and the referenced file name suggests a 'declaration' ('oswiadczenie'), it could also be related to governance or audit confirmation. Since the document is clearly a *signature block* and not the content of the report, and it references a management declaration, 'MDA' (Management's detailed explanation of financial results, business trends, and outlook) is a plausible category for the underlying document being signed, or 'AR' (Audit Report / Information) if it's an auditor's signature. Given the explicit reference to 'oswiadczenie zarzadu' (management statement), MDA is slightly favored over AR, although the structure itself is metadata about a filing. Considering the context of financial filings, a management declaration often accompanies the main financial statements. Since the text is only the signature metadata, and not the report content, we must rely on the referenced file name. 'oswiadczenie zarzadu' translates to 'management statement'. This aligns best with the scope of 'Management Reports' (MDA). If this were a simple announcement of a report, it would be RPA/RNS, but this is the signature block of a specific document. I will classify this as MDA based on the content referenced in the signature block ('oswiadczenie zarzadu').
2022-03-31 Polish
Oświadczenie zarządu skonsolidowane sprawozdanie za 2021
Management Reports Classification · 99% confidence The document is a formal declaration ('OŚWIADCZENIE ZARZĄDU') dated March 31, 2022, from the Management Board of PHARMENA S.A. It explicitly states that the consolidated financial statements ('skonsolidowane sprawozdanie finansowe') and the management report ('Sprawozdanie Zarządu z działalności') are prepared in accordance with applicable accounting principles and present a true and fair view of the company's financial position and performance. This type of document, which contains management assertions about the accuracy of financial reporting and the management report, is a key component often found within or accompanying a full Annual Report (10-K) or an Interim Report (IR). However, since it is a standalone declaration focusing on the *truthfulness* of the financial statements and management report, and given the context of Polish reporting standards (where this declaration often precedes the full filing), it most closely aligns with the content covered by an Audit Report/Information (AR) or the management discussion/assertions section of a comprehensive report. Given the short length (951 chars) and the focus on the assertion of accuracy for the financial statements and management report, it is a specific component of the annual/interim reporting cycle. It is not a full 10-K, ER, or IR, but rather the formal management sign-off on those documents. The closest fit among the provided codes for a formal statement regarding the accuracy of financial reporting and management's review, separate from a full earnings release or presentation, is 'Audit Report / Information' (AR), as it deals with the veracity of the financial data presentation.
2022-03-31 Polish
Sprawozdanie Audytora z badania skonsolidowanego sprawozdania finansowego za 2021 - podpis
Regulatory Filings Classification · 95% confidence The provided document text consists entirely of XML digital signature blocks ('Signatures', 'SignedInfo', 'SignatureValue', 'KeyInfo', 'X509Data', 'Object', 'QualifyingProperties'). This structure is characteristic of a digitally signed document, often used for regulatory filings in European markets (indicated by Polish identifiers like 'Krajowa Izba Rozliczeniowa S.A.' and file name 'Spraw_z_bad_mssf_sko_2022-03-31_pl.xhtml'). The presence of a specific file reference ('Spraw_z_bad_mssf_sko_2022-03-31_pl.xhtml') suggests this is the signature wrapper for a financial report dated March 31, 2022. Since the content is only the signature block and not the report itself, and it is a formal regulatory artifact, the most appropriate classification is the general 'Regulatory Filings' (RNS) category, as it is not explicitly an AGM, 10-K, ER, or IR, but a required component of a filing. However, given the context of financial reporting, a digitally signed document wrapper often accompanies a formal report. If the underlying document referenced (Spraw_z_bad_mssf_sko_2022-03-31_pl.xhtml) is an Audit Report (AR) or Interim Report (IR), this signature block is just metadata. Since the text itself provides no content from the actual report, RNS is the safest classification for the wrapper itself, but if we infer the underlying document type based on the file name structure (which often implies an audit or statutory filing), AR might be considered. Given the strict rule to classify the provided text, and the text being purely signature metadata, RNS is the most accurate fit for the provided snippet. Revisiting the definitions: 'AR' is for Standalone audit reports. The file name 'Spraw_z_bad_mssf_sko_2022-03-31_pl.xhtml' strongly suggests an audit report ('Spraw z badania' means 'Report on the audit' in Polish) for the period ending March 31, 2022. Since the document length is 5109 characters, it is substantial enough to potentially be the report itself, or a significant part of it, rather than just a short announcement (RPA). Given the strong textual evidence pointing to an audit report, I will classify it as AR, assuming the signature block is attached to or constitutes the primary content of the filing being submitted.
2022-03-31 Polish
Sprawozdanie Audytora z badania skonsolidowanego sprawozdania finansowego za 2021
Report Publication Announcement Classification · 81% confidence The provided document text is extremely short, consisting only of bullet points and hyphens, labeled as 'Raport'. Given the minimal content and the lack of any specific financial data, management discussion, or regulatory headers (like 10-K, ER, IR), it is impossible to definitively classify it as any specific report type (10-K, IR, ER, etc.). Following the 'MENU VS MEAL' rule, if this were an announcement, it would likely be RPA or RNS. However, since the text is essentially empty metadata or a placeholder, the most appropriate fallback for an unclassifiable, minimal regulatory document is 'Regulatory Filings' (RNS). The confidence must be low due to the lack of content.
2022-03-31 German
Sprawozdanie z działalności Grupy Kapitałowej Pharmena za 2021- podpis
Audit Report / Information Classification · 95% confidence The provided document text consists entirely of XML Digital Signature blocks (specifically XAdES signatures) referencing a file named "Grupa_Kapitalowa_Pharmena_Sprawozdanie_z_dzialalnosci_2021.xhtml". The presence of the phrase "Sprawozdanie z działalności" (which translates to 'Report on Activities' or 'Annual Report' in a Polish context) strongly suggests the content is related to a formal annual filing. Given the context of a formal annual report being signed, the most appropriate classification among the provided options is 'Annual Report' (10-K), even though the text itself is just the signature block and not the full report content. The document length (10,007 chars) is substantial enough to be a primary filing, not just a short announcement. If the document were merely an announcement stating the report was available, it would be RPA or RNS. Since this is the signature block *of* the report (or the metadata confirming its integrity), it points to the report itself. FY 2021
2022-03-31 Polish
Sprawozdanie z działalności Grupy Kapitałowej Pharmena za 2021
Management Reports Classification · 99% confidence The document text is titled 'Raport GRUPA KAPITAŁOWA PHARMENA S.A. Sprawozdanie Zarządu za 2021 rok' (Report of PHARMENA S.A. CAPITAL GROUP Management Board Report for 2021). The table of contents lists extensive sections typical of a comprehensive annual report, including 'Wybrane dane finansowe zawierające podstawowe pozycje rocznego skonsolidowanego sprawozdania finansowego' (Selected financial data containing basic items of the annual consolidated financial statement), discussion of strategy, risk factors, and management compensation details (Section 1.42). This structure strongly indicates a full annual report covering the entire fiscal year (2021). Although the Polish term 'Sprawozdanie Zarządu' translates to 'Management Board Report,' in the context of annual filings, this document serves the function of the comprehensive annual filing required by regulators, which corresponds to the '10-K' category in US filings, or a comprehensive Annual Report (AR) if 10-K is strictly for SEC filings. Given the comprehensive nature and the reference to the full year (2021), '10-K' is the most appropriate classification for a full annual performance review, even if the source language is Polish, as it covers the full scope of an annual report.
2022-03-31 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.